Systemic lupus erythematosus (SLE), a complex, chronic autoimmune disease, affects around 3.41 million people globally. Two experts, Ian Bruce, University of Manchester, UK, and Julia Weinmann-Menke, Johannes Gutenberg University Mainz, Germany, discuss the latest SLE Treatment Recommendations from the European League Against Rheumatism (EULAR), which detail advanced management and targeting remission as elevated treatment goals to improve patient outcomes.
EMJ Rheumatology 11 [Supplement 2] . 2024
October 2024
Latest articles
All articles
4 Mins
24th
March
Unravelling Clinical AI: Interview with Nicholas Fuggle
EMJ is delighted to introduce Nicholas Fuggle, Associate Professor in Rheumatology at the University of Southampton, UK, and co-organiser…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
6 Mins
24th
December
Current Applications and Future Roles of AI in Rheumatology
AI is the process of simulation of human intelligence by computer systems. These processes encompass learning, reasoning, and…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
3 Mins
12th
December
Interview: Daniel Wallace
In the late 1980s and early 1990s, we were among the first to suggest that interleukin-6 played a role in lupus. It’s not specific just…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
4 Mins
12th
December
Diagnosing Radiographic Axial Spondyloarthritis: Challenges in a Young Adult Case from Guayaquil
Radiographic axial spondyloarthritis (r-axSpA), formerly known as ankylosing spondylitis (AS), is a chronic inflammatory disease that…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.